Our top pick for
Zendesk Inc is a software-application business based in the US. Zendesk shares (ZEN) are listed on the NYSE and all prices are listed in US Dollars. Zendesk employs 5,050 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$124.56|
|52-week range||$103.28 - $166.60|
|50-day moving average||$119.59|
|200-day moving average||$133.63|
|Wall St. target price||$176.81|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.86|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-06)||N/A|
|1 month (2021-09-13)||8.03%|
|3 months (2021-07-17)||-12.18%|
|6 months (2021-04-16)||-17.14%|
|1 year (2020-10-16)||10.99%|
|2 years (2019-10-17)||83.23%|
|3 years (2018-10-17)||97.84%|
|5 years (2016-10-17)||367.39%|
Valuing Zendesk stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zendesk's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Zendesk's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.7755. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zendesk's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$1.2 billion|
|Gross profit TTM||$779.3 million|
|Return on assets TTM||-4.3%|
|Return on equity TTM||-49.89%|
|Market capitalisation||$14.9 billion|
TTM: trailing 12 months
There are currently 7.1 million Zendesk shares held short by investors – that's known as Zendesk's "short interest". This figure is 1.1% down from 7.2 million last month.
There are a few different ways that this level of interest in shorting Zendesk shares can be evaluated.
Zendesk's "short interest ratio" (SIR) is the quantity of Zendesk shares currently shorted divided by the average quantity of Zendesk shares traded daily (recently around 1.5 million). Zendesk's SIR currently stands at 4.61. In other words for every 100,000 Zendesk shares traded daily on the market, roughly 4610 shares are currently held short.
However Zendesk's short interest can also be evaluated against the total number of Zendesk shares, or, against the total number of tradable Zendesk shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Zendesk's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Zendesk shares in existence, roughly 60 shares are currently held short) or 0.06% of the tradable shares (for every 100,000 tradable Zendesk shares, roughly 60 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Zendesk.
Find out more about how you can short Zendesk stock.
We're not expecting Zendesk to pay a dividend over the next 12 months.
Over the last 12 months, Zendesk's shares have ranged in value from as little as $103.28 up to $166.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zendesk's is 1.1942. This would suggest that Zendesk's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Zendesk, Inc. , a software development company, provides software as a service solutions for organizations in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. Its flagship product is Zendesk Support, a system for tracking, prioritizing, and solving customer support tickets across various channels. The company also offers Zendesk Chat, a live chat software to connect with customers on Websites, applications, and mobile devices; Zendesk Talk, a cloud-based call center software; Zendesk Guide, a knowledge base that powers customer self-service and support agent productivity; Zendesk Gather, a community forum software that allows customer end-users to connect and collaborate; Zendesk Sell, a sales customer relationship management (CRM) product solution to enhance productivity, processes, and pipeline visibility; and Zendesk Explore, which provides analytics for organizations to measure and enhance the customer experience. In addition, it provides Zendesk Sunshine, a CRM platform; Sunshine Conversations, a messaging platform solution; Zendesk Embeddables, which allow developers to embed experiences on the Web and mobile applications; Zendesk APIs that allow users to build custom integrations and interact with Zendesk data; and Zendesk Apps that enable organizations to customize Zendesk product and platform solution interfaces and optimize workflow through plug-ins, as well as Zendesk Suite, an omnichannel offering, which combines its solutions. The company was founded in 2007 and is headquartered in San Francisco, California. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.